A single pre-operative intravesical electromotive (EMDA) instillation of mitomycin-C (MMC) improves a patient's risk of non-muscle invasive bladder cancer (NMIBC) recurrence more than a single post-operative intravesical passive instillation, according to new research from investigators in Italy. This preventive measure can also enhance a patient's disease-free interval. These data was presented during the 105th Annual Meeting of the American Urological Association (AUA)...
More...
More...